FT836 Trial
Phase 1
113
about 4.2 years
18+
5 sites in CA, MN, PA +1
What this study is about
This trial is testing FT836, a medication, in people with advanced solid tumors. The goal is to see if FT836 is safe and well-tolerated when used alone or with other medications like paclitaxel, trastuzumab, or cetuximab.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cetuximab
- 2.Take FT836
- 3.Take Paclitaxel
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cetuximab, paclitaxel (Taxane chemotherapy; stabilizes microtubules), trastuzumab (Monoclonal antibody; targets HER2 protein on cancer cells)
injection (Injection), injection, intravenous
Primary: Number of participants with dose limiting toxicities (DLTs)
Secondary: Duration of Response (DOR), Overall Response Rate (ORR), Overall Survival (OS), Progression-Free Survival (PFS)
Oncology